Dissecting the Role of Desmoplakin in Inflammation in Cardiomyopathy
剖析桥粒斑蛋白在心肌病炎症中的作用
基本信息
- 批准号:10606326
- 负责人:
- 金额:$ 4.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdrenergic AgentsAffectArrhythmiaBiological AssayCalciumCardiacCardiac MyocytesCardiomyopathiesCell CommunicationCell DeathCell LineCellsClinicalClustered Regularly Interspaced Short Palindromic RepeatsCoculture TechniquesComplexCytoskeletonDNA Sequence AlterationDSPP geneDataDefectDesmosomesDevelopmentDilated CardiomyopathyDiseaseDisease ProgressionEpigenetic ProcessExposure toFibroblastsFunctional disorderFutureGap JunctionsGene ExpressionGenesGenetic TranscriptionHeartHeart DiseasesHeart failureHeterozygoteHumanImmuneImmunologicsIndividualInflammasomeInflammationInflammatoryIntercalated discIntercellular JunctionsIntermediate FilamentsInvestigationLeadLeftLeft Ventricular FunctionLeft ventricular structureLinkMacromolecular ComplexesMagnetic ResonanceMeasuresMediatingMediatorMitosisModelingMutationMyocarditisNatureNeonatalNormal CellPathologicPathologyPathway interactionsPatientsPhenotypePhosphotransferasesPositron-Emission TomographyProductionProteinsRattusRoleSeverity of illnessSignal TransductionSkinSmall Interfering RNATestingTherapeuticTissue-Specific Gene ExpressionTissuesVariantVentricularVentricular ArrhythmiaVisualizationWorkarrhythmogenic cardiomyopathycardiac tissue engineeringclinical imagingcytokinedesmoplakindifferential expressiondisorder preventioneffectiveness evaluationheart imagingheart rhythmimmune activationimmunomodulatory therapiesimmunoregulationinduced pluripotent stem cellinduced pluripotent stem cell derived cardiomyocytesinflammatory modulationinnate immune pathwaysinsightlink proteinmRNA Expressionpathogenpreventprognostic indicatorprogramsprotein expressionrecruitresponsesmall moleculestem cell modeltranscriptome sequencing
项目摘要
Project Summary/Abstract
Desmoplakin is an elongated protein that links the desmosomal components to the cytoskeleton through
intermediate filaments. Heterozygous truncation mutations in the DSP gene, which encodes desmoplakin,
cause arrhythmogenic cardiomyopathy (AC) impacting the left ventricle. A striking feature associated with
DSP truncation variants (DSPtv) is a prominent inflammatory component, and this inflammation can be well
visualized through cardiac imaging using magnetic resonance or positron emission tomography. The effect of
DSP truncations in mediating cardiac inflammation is not well understood. The nature of DSP truncations
implies that haploinsufficiency or reduction of desmoplakin protein is contributory feature of left ventricular
cardiomyopathy with inflammation. To begin to characterize the transcriptional program associated with DSP-
cardiomyopathy, I analyzed RNA-sequencing from neonatal rat ventricular cardiomyocytes with siRNA to
reduce expression of DSP. Analysis of the differentially expressed genes in siRNA-treated cardiomyocytes
identified immune chemotactic pathways as having increased expression. Of particular note were several
genes connected to pyroptosis, an immunologically active form of cell death. Taken together, these data
suggest that innate immune pathways may contribute significantly to DSP-associated cardiomyopathy. I
hypothesize that reduction of desmoplakin promotes excessive inflammasome activation in cardiomyocytes
that results in aberrant calcium handling and pro-arrhythmogenic heterocellular junctions. In Aim 1 of this
proposal, I will assess this inflammatory component of DSP-cardiomyopathy in human-induced pluripotent
stem cell (hiPSC) lines with distinct DSP truncations derived from individuals with inflammatory-arrhythmogenic
cardiomyopathy. To characterize 2D- and 3D-hiPSC models, I will assess whether DSP haploinsufficiency is
sufficient to drive expression of inflammasome components. I will then examine DSPtvs for their effects on
contractility and calcium transients in response to pathogen- and damage-derived activators of the
inflammasome. I will conduct coculture assays of hiPSC-derived cardiomyocytes and fibroblasts to evaluate
the inflammatory modulation of heterocellular junctions and cardiac conduction in DSP-cardiomyopathy. In
Aim 2 of the proposal, I will modulate innate immune activation in hiPSC-derived cardiomyocyte models using
siRNA, small molecule inhibition, and epigenetic modulation strategies. These studies will target Never in
Mitosis A-related Kinase 7 (NEK7), an inflammasome component with differential gene expression in heart
failure. The proposed studies will expand from observations in patients with DSPtvs and define the
inflammatory triggers refining the distinct pathology related to DSP-mediated disease. In particular, the
findings from this study have implications for other forms of cardiomyopathy driven by fibrotic transformation
such as dilated cardiomyopathy and heart failure.
项目概要/摘要
桥粒斑蛋白是一种细长的蛋白质,通过以下方式将桥粒成分与细胞骨架连接起来:
中间丝。 DSP 基因中的杂合截断突变,该基因编码桥粒斑蛋白,
导致影响左心室的致心律失常性心肌病 (AC)。一个显着的特征与
DSP 截短变体(DSPtv)是一种重要的炎症成分,这种炎症可以很好地缓解
使用磁共振或正电子发射断层扫描通过心脏成像进行可视化。的效果
DSP 截短在介导心脏炎症中的作用尚不清楚。 DSP 截断的本质
暗示单倍体不足或桥粒斑蛋白减少是左心室的重要特征
伴有炎症的心肌病。开始表征与 DSP 相关的转录程序
心肌病时,我使用 siRNA 分析了新生大鼠心室心肌细胞的 RNA 测序,
减少DSP的表达。 siRNA处理心肌细胞差异表达基因分析
确定免疫趋化途径的表达增加。特别值得注意的是几个
与焦亡有关的基因,焦亡是细胞死亡的一种免疫活性形式。综合起来,这些数据
表明先天免疫途径可能对 DSP 相关心肌病有显着影响。我
假设桥粒斑蛋白的减少会促进心肌细胞中炎症小体的过度激活
这导致异常的钙处理和致心律失常的异细胞连接。在这个目标1中
建议,我将评估人诱导多能性 DSP 心肌病的炎症成分
具有独特 DSP 截短的干细胞 (hiPSC) 系,源自患有炎症性心律失常的个体
心肌病。为了表征 2D-和 3D-hiPSC 模型,我将评估 DSP 单倍体不足是否
足以驱动炎症小体成分的表达。然后我将检查 DSPtvs 对
响应于病原体和损伤衍生的激活剂的收缩性和钙瞬变
炎症小体。我将对 hiPSC 衍生的心肌细胞和成纤维细胞进行共培养测定,以评估
DSP 心肌病中异细胞连接和心脏传导的炎症调节。在
该提案的目标 2,我将使用调节 hiPSC 衍生心肌细胞模型中的先天免疫激活
siRNA、小分子抑制和表观遗传调节策略。这些研究将针对从不
有丝分裂 A 相关激酶 7 (NEK7),一种在心脏中具有差异基因表达的炎症体成分
失败。拟议的研究将从对 DSPtvs 患者的观察进行扩展,并定义
炎症触发因素改善了与 DSP 介导的疾病相关的独特病理学。特别是,
这项研究的结果对纤维化转化驱动的其他形式的心肌病具有影响
例如扩张型心肌病和心力衰竭。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Selgrade其他文献
Daniel Selgrade的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
记忆再巩固中去甲肾上腺素能系统在药物依赖戒断后潜伏心理渴求中的作用
- 批准号:82001404
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
肾上腺素能受体SNPs及PWV、CBP对射血分数保留心衰的发病及药物敏感性的影响
- 批准号:81471402
- 批准年份:2014
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease Modeling
开发基于胶原蛋白的 3D 生物打印微流体平台,用于血管组织工程和疾病建模
- 批准号:
10837289 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别:
The Role and Branching Dynamics of Sympathetic Nerves in Ovarian Folliculogenesis
交感神经在卵巢卵泡发生中的作用和分支动态
- 批准号:
10607058 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别:
Ryanodine receptor structure and function in heart failure
Ryanodine 受体结构和心力衰竭中的功能
- 批准号:
10628917 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别:
Transcriptional and epigenetic regulation of thermogenic adipocyte program
产热脂肪细胞程序的转录和表观遗传调控
- 批准号:
10604352 - 财政年份:2022
- 资助金额:
$ 4.29万 - 项目类别:
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease Modeling
开发基于胶原蛋白的 3D 生物打印微流体平台,用于血管组织工程和疾病建模
- 批准号:
10468156 - 财政年份:2021
- 资助金额:
$ 4.29万 - 项目类别: